Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

e-Cigarettes Versus NRT Gum for Smoking Cessation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01925781
Recruitment Status : Terminated (IND required)
First Posted : August 20, 2013
Results First Posted : January 14, 2016
Last Update Posted : January 14, 2016
Sponsor:
Information provided by (Responsible Party):
Creighton University

Brief Summary:
This is a randomized trial comparing electronic cigarettes (e-Cigarettes) to nicotine gum for smoking cessation. Participants will be randomly assigned to either e-cigarette use or nicotine gum use during a quit attempt. All participants will have a one hour meeting with a tobacco treatment specialist to develop a quit plan and set a quit date. Quit status will be determined at 12 weeks after the quit date. Continued use of nicotine replacement (either e-Cigarette or nicotine gum) and satisfaction with the treatment assignment will be evaluated.

Condition or disease Intervention/treatment Phase
Nicotine Addiction Smoking Cessation Drug: Nicotine polacrilex Other: STAM 1100mAh CE4 eGo Clearomizer Phase 4

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 10 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: e-Cigarettes Versus Nicotine Replacement Therapy for Smoking Cessation
Study Start Date : August 2013
Actual Primary Completion Date : November 2013
Actual Study Completion Date : November 2013

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: e-Cigarette
STAM 1100mAh CE4 eGo Clearomizer e-Cigarette
Other: STAM 1100mAh CE4 eGo Clearomizer
Other Names:
  • e-Cigarette
  • electronic nicotine delivery device

Active Comparator: Nicotine polacrilex
Nicotine Replacement gum
Drug: Nicotine polacrilex
2 mg and 4 mg gum will be used according to the FDA approved product labelling
Other Name: Nicotine Gum




Primary Outcome Measures :
  1. Sustained Abstinence [ Time Frame: 12 weeks ]
    No smoking at 12 weeks after the predetermined quit date with a 5 day grace period. Self-report will be biochemically confirmed with expired carbon monoxide (CO) and salivary cotinine.


Secondary Outcome Measures :
  1. Point Prevalence Abstinence [ Time Frame: 12 weeks ]
    No smoking in the previous 7 days. Self report will be biochemically confirmed with expired CO and salivary cotinine.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   19 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Smokes at least five cigarettes per day
  • No current or previous regular use of e-cigarettes
  • Ready to quit smoking

Exclusion Criteria:

  • Use of smokeless or pipe tobacco
  • Smoke more than 40 cigarettes per day
  • Pregnant or breastfeeding
  • Unable to chew gum due to dental or jaw problems
  • Myocardial infarction (heart attack) within the previous 12 months
  • Hypersensitivity to propylene glycol or nicotine gum

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01925781


Locations
Layout table for location information
United States, Nebraska
Creighton University
Omaha, Nebraska, United States, 68178
Sponsors and Collaborators
Creighton University
Investigators
Layout table for investigator information
Principal Investigator: Amy J Arouni, MD Creighton University
Layout table for additonal information
Responsible Party: Creighton University
ClinicalTrials.gov Identifier: NCT01925781    
Other Study ID Numbers: 13-16684
First Posted: August 20, 2013    Key Record Dates
Results First Posted: January 14, 2016
Last Update Posted: January 14, 2016
Last Verified: December 2015
Keywords provided by Creighton University:
Smoking Cessation
Nicotine Addiction
e-Cigarette
electronic nicotine delivery device
electronic cigarette
nicotine replacement therapy
Additional relevant MeSH terms:
Layout table for MeSH terms
Behavior, Addictive
Compulsive Behavior
Impulsive Behavior
Nicotine
Ganglionic Stimulants
Autonomic Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Nicotinic Agonists
Cholinergic Agonists
Cholinergic Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action